A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer
published in: Clinical Cancer Research
date of publication: 2010-09-13
language: English
main subject: estrogen-receptor positive breast cancer, immunohistochemistry, estrogen, tamoxifen
Cites articles 33
Date
Title
Article - wd:Q34268261